Angiography Catheter Market
Angiography Catheter Market Analysis by Cerebral, Visceral, Coronary, Renal, Micro, and Pigtail Catheters for Coronary, Endovascular, Neurology, and Oncology from 2024 to 2034
Analysis of Angiography Catheter Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Angiography Catheter Market Outlook (2024 to 2034)
The global angiography catheter market size is projected to be valued at US$ 1.57 billion in 2024 and climb to a size of US$ 3.05 billion by 2034, expanding at a CAGR of 6.9% between 2024 and 2034.
Prevalence of conditions such as coronary artery diseases, peripheral vascular diseases, and strokes has increased globally, necessitating efficient diagnostic tools for accurate assessment and treatment planning. Angiography catheters play a pivotal role in this domain, enabling healthcare professionals to visualize and identify blockages or abnormalities within blood vessels with exceptional precision.
Angiography catheters are specialized medical devices used in minimally invasive procedures to visualize blood vessels and diagnose various cardiovascular conditions. These catheters are designed to navigate through the vascular system, allowing for the injection of contrast material and imaging of blood flow using X-rays or other imaging technologies such as therapeutic catheters, surgical catheters, and coronary microcatheters.
Key Market Growth Drivers
- Rising incidence of heart disease and related conditions worldwide is a major driver. Angiography catheters aid in the precise diagnosis and treatment of these ailments.
- Continuous innovations in catheter designs, materials, and imaging technologies have enhanced their efficiency, safety, and precision during procedures, thus driving market growth.
- Patients and healthcare providers prefer minimally invasive procedures due to reduced recovery time, minimal scarring, and lower risk of complications, leading to a higher demand for angiography catheters.
- The aging population is more susceptible to cardiovascular diseases, thereby increasing the need for diagnostic and treatment procedures involving angiography catheters.
|Angiography Catheter Market Size (2023A)
|US$ 1.47 Billion
|Estimated Market Value (2024E)
|US$ 1.57 Billion
|Forecasted Market Value (2034F)
|US$ 3.05 Billion
|Global Market Growth Rate (2024 to 2034)
|North America Market Share (2024)
|Endovascular Segment Growth Rate
(2024 to 2034)
|Key Companies Profiled
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why is There Increasing Demand for Angiography Tools?
“Rising Prevalence of Cardiovascular Diseases Driving Demand for Advanced Diagnostic Tools”
Cardiovascular diseases (CVDs) include a wide range of conditions that affect the heart and blood arteries, such as coronary artery disease, heart failure, stroke, and peripheral arterial disease. This increase in cardiovascular diseases has resulted in a surge in the demand for diagnostic procedures such as angiography, in which cardiovascular catheters play an important role. Sedentary habits, unhealthy dietary choices, tobacco use, stress, and escalating obesity rates collectively contribute to a heightened risk of developing cardiovascular conditions.
Enhanced awareness about the importance of early diagnosis and timely treatment among both patients and healthcare providers has augmented the demand for cerebral angiography procedures. The evolving landscape of medical innovations has resulted in the development of advanced catheters, such as those with improved flexibility, better navigability, and enhanced imaging capabilities.
“Susceptibility of Elderly Individuals to Heart-Related Issues”
As individuals age, they become more susceptible to cardiovascular diseases and related conditions, elevating the need for diagnostic and treatment procedures. The aging demographic experiences a higher incidence of conditions such as atherosclerosis, coronary artery disease, and peripheral vascular diseases, necessitating interventions facilitated by angiography catheters for precise diagnosis and effective treatment.
This demographic trend corresponds with an increased prevalence of comorbidities, making minimally invasive procedures using angiography catheters a preferable choice for older patients who might not withstand the rigors of traditional open surgeries.
What is Adversely Affecting Sales of Angiography Catheters Negatively?
“Stringent Regulatory Framework and Lengthy Product Approval Processes”
Regulatory bodies worldwide impose rigorous standards and approval processes to ensure the safety, efficacy, and quality of medical devices, including angiography catheters. The lengthy and intricate approval procedures significantly delay the introduction of new products into the market. The extensive documentation, clinical trials, and regulatory submissions often take a considerable amount of time, delaying the commercialization of innovative catheter technologies.
This prolonged timeline not only affects the ability of companies to introduce advancements promptly but also increases development costs, which can eventually impact the final product pricing. Meeting regulatory requirements demands substantial investments in research, development, and compliance activities. Changes in regulatory guidelines and standards necessitate continuous adaptation by manufacturers, leading to further challenges in maintaining compliance and staying updated with the latest requirements.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Strategies Should New Companies Follow to Drive Sales of Angiography Supplies?
“Focus on Providing High-Quality Catheters at Competitive Prices”
Start-ups should focus on developing cutting-edge technologies that enhance catheter performance, such as improved navigational capabilities, better imaging modalities, or materials that mitigate risks during procedures. Innovation could also involve the creation of specialized catheters for niche procedures, addressing unmet needs within the cardiovascular intervention landscape.
New manufacturers can team up with established healthcare institutions, universities, or research centers to conduct clinical trials, validate their products, and gain credibility. Understanding the pain points of healthcare providers and patients and addressing issues related to ease of use, safety, and cost-effectiveness can significantly differentiate the offerings of emerging companies.
There are distinct angiography catheter market trends across various regions. North America stands as a frontrunner, boasting a leading market share due to its robust healthcare infrastructure, substantial healthcare spending, and high prevalence of cardiovascular diseases. The market in East Asia demonstrates rapid expansion driven by evolving healthcare infrastructure, rising disposable incomes, and a substantial patient population.
What is the Demand Outlook for Angiographic Catheters in the United States?
“Rising Adoption of Cutting-edge Technologies to Improve Patient Outcomes”
|Market Value (2024E)
|US$ 447 Million
|Growth Rate (2024 to 2034)
|Projected Value (2034F)
|US$ 959 Million
With high focus on advancing healthcare delivery and patient outcomes, healthcare facilities in the United States readily embrace innovative medical devices like angiography catheters. The emphasis of the country on research and development, coupled with substantial investments in healthcare, fosters an environment conducive to the adoption of these devices, thereby driving the angiography catheter market growth.
Rising incidence of heart conditions and associated ailments prompts a greater need for precise diagnostic tools and minimally invasive treatment options. This high disease burden stimulates a consistent demand for these devices across hospitals, clinics, and diagnostic centers throughout the country.
The favorable regulatory landscape in the United States supports the introduction and adoption of new medical devices. Regulatory bodies like the FDA (Food and Drug Administration) maintain stringent but transparent approval processes, ensuring safety and efficacy standards while also facilitating relatively swift market access for innovative medical technologies like angiography catheters.
How Does Japan Contribute to the Angiography Catheter Market Share in East Asia?
“High Demand for Angiography Catheters Driven by Advanced Healthcare Infrastructure”
|Market Value (2024E)
|US$ 138 Million
|Growth Rate (2024 to 2034)
|Projected Value (2034F)
|US$ 288 Million
The population in Japan is rapidly aging, with a considerable proportion suffering from cardiovascular diseases prevalent among older individuals. This demographic trend fuels the necessity for advanced diagnostic and treatment methods, where angiography catheters play a crucial role in accurate diagnosis and minimally invasive interventions. Japan is synonymous with advanced technological advancements in the healthcare sector.
The country continually invests in research and development, fostering innovation in medical devices. This commitment to technological progress contributes to the evolution of angiography catheters, leading to the development of more efficient and precise devices. Emphasis on quality healthcare and patient safety ensures the swift integration of innovative angiography catheters into clinical practices, stimulating market expansion.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The global market is categorized into various segments, each offering unique opportunities and applications, reveals Fact.MR in its recent angiography catheter market analysis. Considering end-users, hospitals, diagnostic centers, and ambulatory surgical centers constitute the primary stakeholders, with differing requirements and preferences for these specialized medical devices.
Which End User Segment Contributes to the High Growth of the Angiography Catheter Market Size?
“Extensive Angiographic Catheter Use in Hospitals Due to Presence of Skilled Workforce”
|Segment value (2024E)
|US$ 1.03 Billion
|Growth Rate (2024 to 2034)
|Projected Value (2034F)
|US$ 2.01 Billion
Hospitals stand as the primary end-users of angiography catheters. Hospitals serve as crucial centers for performing a wide array of medical procedures, including diagnostic and interventional cardiology procedures, which extensively rely on angiography catheters. With a substantial patient influx requiring cardiovascular examinations and treatments, hospitals have a consistent demand for these diagnostic catheters, making them primary consumers.
Inclination to adopt newer and more sophisticated angiography catheters that offer enhanced imaging capabilities, improved navigational precision, and reduced risks for patients undergoing procedures makes hospitals a primary end user. The presence of skilled healthcare professionals within hospital settings, including cardiologists, interventional radiologists, and specialized nursing staff, fosters the utilization of angiography catheters. These professionals are adept at handling and utilizing these devices effectively, promoting their use and influencing the preference for specific catheter types or brands based on their experience and outcomes.
Key players in the angiography catheter market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Terumo Interventional Systems, and Cook Medical lead this sphere, wielding considerable market influence. These industry leaders constantly strive to maintain and expand their market presence through a combination of strategies, including relentless research and development initiatives aimed at innovating new catheter designs, materials, and imaging technologies.
- Teleflex gained the United States FDA approval in February 2022 for an expanded indication for the use of specialty catheters and coronary guidewires in crossing chronic complete occlusion percutaneous coronary procedures.
- Philips announced the first minimally invasive heart surgery in July 2021, utilizing its real-time 3D intracardiac echocardiography device.
Segmentation of Angiography Catheter Market Research
By Product Type :
- Cerebral Catheters
- Visceral Catheters
- Coronary Catheters
- Renal Catheters
- Pigtail Catheter
By Application :
By Technology :
By End User :
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
By Region :
- North America
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
- FAQs -
Which segment of the angiography catheter market accounts for a leading share?
Based on end-user, hospitals are estimated to hold 65.7% share of the angiography catheter market in 2024.
What is the sales value of angiography catheters?
Worldwide sales of angiography catheters are estimated at US$ 1.57 billion in 2024.
What is the sales forecast for angiography catheters for 2034?
The global angiography catheter market is forecasted to reach US$ 3.05 billion by 2034-end.
What is the demand growth projection for angiography catheters?
Demand for angiography catheters is projected to rise at a CAGR of 6.9% through 2034.
At what rate is the East Asia market predicted to grow?
The East Asia market is forecasted to expand at a CAGR of 7.8% through 2034.
What is the growth projection for the market in North America?
The market for angiography catheters in North America is forecasted to expand at 7.2% CAGR.